RoSA Influenza Drug Market to 2032
Overview
The RoSA Influenza Drug Market is expected to reach a 154.20 USD Million by 2032 and is projected to grow at a CAGR of 4.99% from 2025 to 2032.
Revenue, 2024 (USD Million)
112.20
Forecast, 2032 (USD Million)
154.20
CAGR, 2024 - 2032
4.99%
Report Coverage
RoSA
RoSA Influenza Drug Market 2018-2032 USD Million
RoSA Influenza Drug Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 112.20 USD Million
- Projected Market Size (2032): 154.20 USD Million
- CAGR (2025-2032): 4.99%
Key Findings of RoSA Influenza Drug Market
- The RoSA Influenza Drug Market was valued at 112.20 USD Million in 2024.
- The RoSA Influenza Drug Market is likely to grow at a CAGR of 4.99% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 194.67 USD Million
- The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 5.82% during the forecast period from 2024 to 2032.
RoSA Influenza Drug Market Scope
RoSA Influenza Drug Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Homecare
- Hospitals
Treatment
- Drugs
- Vaccines
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Age
- Pediatrics
- Adults
Type
- Influenza C
- Influenza B
- Influenza A
RoSA Influenza Drug Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 112.20 USD Million |
| Market Value in 2032 | 154.20 USD Million |
| CAGR (2025-2032) | 4.99% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Treatment,Route of Administration,Age,Type |
Regional Insights:
-
Leading Market (2024-2032): RoSA, leading in terms of revenue 112.20 USD Million in 2024
- Key Country: RoSA, leading in terms of revenue with value of 112.20 USD Million in 2024.
Segments and Scope
-
RoSA Influenza Drug Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in RoSA Influenza Drug Market to 2032 with a revenue of 61.51 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in RoSA Influenza Drug Market to 2032 with a Growth rate of 5.34 % in forecast period 2025-2032.
-
RoSA Influenza Drug Market to 2032, By End User
- Hospitals is the largest segment in RoSA Influenza Drug Market to 2032 with a revenue of 80.62 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in RoSA Influenza Drug Market to 2032 with a Growth rate of 5.17 % in forecast period 2025-2032.
-
RoSA Influenza Drug Market to 2032, By Treatment
- Vaccines is the largest segment in RoSA Influenza Drug Market to 2032 with a revenue of 194.67 USD Million in the year 2024.
- Vaccines is the Fastest growing segment in RoSA Influenza Drug Market to 2032 with a Growth rate of 5.02 % in forecast period 2025-2032.
-
RoSA Influenza Drug Market to 2032, By Route of Administration
- Oral is the largest segment in RoSA Influenza Drug Market to 2032 with a revenue of 47.30 USD Million in the year 2024.
- Oral is the Fastest growing segment in RoSA Influenza Drug Market to 2032 with a Growth rate of 5.82 % in forecast period 2025-2032.
-
RoSA Influenza Drug Market to 2032, By Age
- Adults is the largest segment in RoSA Influenza Drug Market to 2032 with a revenue of 57.03 USD Million in the year 2024.
- Pediatrics is the Fastest growing segment in RoSA Influenza Drug Market to 2032 with a Growth rate of 4.53 % in forecast period 2025-2032.
-
RoSA Influenza Drug Market to 2032, By Type
- Influenza A is the largest segment in RoSA Influenza Drug Market to 2032 with a revenue of 51.69 USD Million in the year 2024.
- Influenza A is the Fastest growing segment in RoSA Influenza Drug Market to 2032 with a Growth rate of 5.53 % in forecast period 2025-2032.
RoSA Influenza Drug Market Company Share Analysis
| Company Name |
|
||
| Sanofi | |||
| AstraZeneca | |||
| GSK plc. | |||
| CSL | |||
| F. Hoffmann-La Roche Ltd. | |||
RoSA Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million
RoSA Influenza Drug Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoSA Influenza Drug Market is segmented based on Segmentation Distribution Channel,End User,Treatment,Route of Administration,Age,Type.
RoSA Influenza Drug Market was valued at USD 112.20(Revenue in USD Million) in 2022.
RoSA Influenza Drug Market is projected to grow at a CAGR of 4.99% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the RoSA Influenza Drug Market, holding a largest market share of 194.67 USD Million in 2024
RoSA Influenza Drug Market Scope
RoSA Influenza Drug Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Homecare
- Hospitals
Treatment
- Drugs
- Vaccines
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Age
- Pediatrics
- Adults
Type
- Influenza C
- Influenza B
- Influenza A
Frequently Asked Questions
The RoSA Influenza Drug Market is segmented based on Segmentation Distribution Channel,End User,Treatment,Route of Administration,Age,Type.
RoSA Influenza Drug Market was valued at USD 112.20(Revenue in USD Million) in 2022.
RoSA Influenza Drug Market is projected to grow at a CAGR of 4.99% during the forecast period of 2024 to 2032.
The estimated market value of the RoSA Influenza Drug Market for final year is USD 154.20 (USD Million).
RoSA Influenza Drug Market Company Profiling
Frequently Asked Questions
The RoSA Influenza Drug Market is segmented based on Segmentation Distribution Channel,End User,Treatment,Route of Administration,Age,Type.
RoSA Influenza Drug Market was valued at USD 112.20(Revenue in USD Million) in 2022.
RoSA Influenza Drug Market is projected to grow at a CAGR of 4.99% during the forecast period of 2024 to 2032.
The estimated market value of the RoSA Influenza Drug Market for final year is USD 154.20 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.